Skip to content
Company Analysis

STAAR Surgical Company STAA

A comprehensive view of key metrics, scores, and financial health for STAAR Surgical Company

Overview of STAAR Surgical Company

STAA NGM
Healthcare Medical Instruments & Supplies Framework: Medical Devices & Diagnostics Small Cap
STAAR Surgical Company (STAA), is a Small Cap company, in the Medical Instruments & Supplies industry, last closed at $28.37, about 69.6% overvalued vs fair value, +66.1% 1Y return, ranked 328/1122 in sector.
USD 28.37
-1.83%
(Delayed)
• Vol 90d: 61.3%
52-Week Range
Market Cap
$1.46B
Enterprise Value
$1.32B
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Weak
Valuation
Fair
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Weak
Valuation
Fair
Completeness: 82%
Confidence: 53%
Updated: Mar 8
Top Beats

Quick Facts

Website https://www.staar.com
HQ Lake Forest, CA
Employees 1,157
Fiscal year Dec 31

Next Events

Earnings Aug 12 Estimated

Fair Value Snapshot

Bear Base Bull
$7
$9
$10
Current: $28.37 -70% vs base

Engine Room Money Flow™

Small Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$313.9M
-2.6%%
Gross Profit
$239.6M
-5.2%%
Operating Income (GAAP)
$-12.6M
-144.9%%
EBITDA
$-5.7M
-117.2%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
76.3%
Excellent

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$2.1M

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
6
Active Leaks
1/6
Improving
0
High Impact
5
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating STAAR Surgical Company's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
60
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Strong
78
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 92% Coverage
Trade-Off Triangle Visualization A ternary plot showing STAA's balance between Growth (22.6%), Profitability (46.0%), and Safety (31.5%). Growth 23% Safety 32% Profitability 46%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

32th percentile vs peers
32
Key Signals
Revenue CAGR 3Y 10.8% 59p Rev Growth YoY -2.6% 25p Asset Growth YoY 4.3% 66p EPS Growth YoY -1.95 6p
Strengths
  • Gross Profit Margin in top 20% of peers (76.3%, 87th percentile)
  • Interest Coverage (EBITDA) in top 20% of peers (19.73, 85th percentile)
  • Equity/Assets in top 20% of peers (78.0%, 80th percentile)
  • Consistently strong margins across 3 metrics
Risks
  • EPS Growth YoY in bottom 20% of peers (-1.95)

Profitability

65th percentile vs peers
66
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

45th percentile vs peers
45
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for STAAR Surgical Company.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$8.62
- - -
-69.6% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000